Biomarkers for Response to Anti-PD-1/Anti-PD-L1 Immune Checkpoint Inhibitors: A Large Meta-Analysis.
Arshiya MariamSuneel KamathKimberly SchvederHoward L McLeodDaniel M Rotroff
Published in: Oncology (Williston Park, N.Y.) (2023)
Although some biomarkers consistently performed better, heterogeneity in performance was observed across cancer types, and additional research is needed to identify highly accurate and precise biomarkers for widespread clinical use.